Medical Developments International Limited (ASX:MVP)

ASX:MVP Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Market Capitalization	57	45	62	35	67	104
Market Cap Growth	-10.53%	-28.18%	77.27%	-47.74%	-35.75%	-67.54%
Enterprise Value	38	29	46	22	32	79
Last Close Price	0.51	0.40	0.55	0.39	0.75	1.40

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
PE Ratio	96.24	71.09	659.17	-	-	-
Forward PE	40.80	65.83	22.54	208.39	208.39	208.39
PS Ratio	1.35	1.05	1.59	1.05	2.07	4.74
PB Ratio	1.03	0.80	1.12	0.76	0.82	1.82
P/TBV Ratio	1.15	0.89	1.26	0.88	0.88	2.01
P/FCF Ratio	10.90	8.45	-	-	-	-
P/OCF Ratio	9.99	7.74	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
EV/Sales Ratio	0.89	0.69	1.19	0.65	1.00	3.59
EV/EBITDA Ratio	8.93	7.44	27.77	-	-	-
EV/EBIT Ratio	15.82	12.35	329.69	-	-	-
EV/FCF Ratio	7.17	5.59	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Debt / Equity Ratio	0.03	0.03	0.04	0.05	0.03	0.05
Debt / EBITDA Ratio	0.39	0.39	1.02	-	-	-
Debt / FCF Ratio	0.32	0.32	-	-	-	-
Net Debt / Equity Ratio	-0.35	-0.35	-0.29	-0.16	-0.27	-0.31
Net Debt / EBITDA Ratio	-4.98	-4.98	-9.47	0.60	1.39	1.55
Net Debt / FCF Ratio	-3.74	-3.74	32.61	0.64	1.21	1.47
Asset Turnover	0.65	0.65	0.62	0.41	0.33	0.23
Inventory Turnover	1.45	1.45	1.19	1.02	1.31	1.05
Quick Ratio	4.55	4.55	3.26	1.76	2.16	2.54
Current Ratio	5.77	5.77	4.54	2.74	2.75	3.28
Return on Equity (ROE)	1.13%	1.13%	0.19%	-64.53%	-8.09%	-19.76%
Return on Assets (ROA)	2.28%	2.28%	0.14%	-11.00%	-11.18%	-8.15%
Return on Invested Capital (ROIC)	6.61%	6.33%	0.20%	-28.96%	-34.98%	-33.55%
Return on Capital Employed (ROCE)	4.10%	4.10%	0.20%	-28.50%	-20.20%	-15.30%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 10, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Earnings Yield	1.09%	1.41%	0.15%	-117.27%	-8.39%	-11.92%
FCF Yield	9.17%	11.84%	-0.78%	-33.11%	-27.33%	-11.50%
Buyback Yield / Dilution	-4.45%	-4.45%	-29.95%	-2.41%	-18.23%	-4.11%
Total Shareholder Return	-4.45%	-4.45%	-29.95%	-2.41%	-18.23%	-4.11%

Data Source: S&P Global Market Intelligence Last updated: Aug 19, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 10, 2026

Data Sources Report a data error